BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32832146)

  • 21. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis.
    Fang S; Wang L; Jia C
    Thromb Res; 2010 May; 125(5):e197-201. PubMed ID: 20100625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-8 Gene -251 A/T (rs4073) Polymorphism and Coronary Artery Disease Risk: A Meta-Analysis.
    Zhang S; Gao Y; Huang J
    Med Sci Monit; 2019 Mar; 25():1645-1655. PubMed ID: 30826813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 gene polymorphisms and CAD risk: a meta-analysis.
    Yang Y; Zhang F; Skrip L; Lei H; Wang Y; Hu D; Ding R
    Mol Biol Rep; 2013 Mar; 40(3):2589-98. PubMed ID: 23242654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene polymorphism in IL17A and gene-gene interaction in the IL23R/IL17A axis are associated with susceptibility to coronary artery disease.
    Zhang H; Nie S; Chen Q; Wang P; Xu C; Tu X; Zhang L; Kenneth Wang Q; Zha L
    Cytokine; 2023 Apr; 164():156142. PubMed ID: 36804259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan.
    Hsu LA; Ko YL; Chang CJ; Hu CF; Wu S; Teng MS; Wang CL; Ho WJ; Ko YS; Hsu TS; Lee YS
    Atherosclerosis; 2006 Mar; 185(1):143-9. PubMed ID: 16054149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common gene polymorphism in ATP-binding cassette transporter A1 and coronary artery disease: A genetic association study and a structural analysis.
    Karimian M; Momeni A; Farmohammadi A; Behjati M; Jafari M; Raygan F
    J Cell Biochem; 2020 Jun; 121(5-6):3345-3357. PubMed ID: 31943326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis.
    Hou H; Wang C; Sun F; Zhao L; Dun A; Sun Z
    Inflamm Res; 2015 Sep; 64(9):707-20. PubMed ID: 26174156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stratified meta-analysis by ethnicity revealed that ADRB3 Trp64Arg polymorphism was associated with coronary artery disease in Asians, but not in Caucasians.
    Chen Y; Liao Y; Sun S; Lin F; Li R; Lan S; Zhao X; Qin J; Rao S
    Medicine (Baltimore); 2020 Jan; 99(4):e18914. PubMed ID: 31977906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of causal effect of APOA5 variants on premature coronary artery disease.
    Wang F; Wang IZ; Ellis S; Archacki S; Barnard J; Hubbard C; Topol EJ; Chen Q; Wang QK
    Ann Hum Genet; 2018 Nov; 82(6):437-447. PubMed ID: 30024021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. There is an association between a genetic polymorphism in the ZNF259 gene involved in lipid metabolism and coronary artery disease.
    Mirhafez SR; Avan A; Khatamianfar S; Ghasemi F; Moohebati M; Ebrahimi M; Ghazizadeh H; Ghayour-Mobarhan M; Pasdar A
    Gene; 2019 Jul; 704():80-85. PubMed ID: 30902787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Connexin37 gene C1019T polymorphism and risk of coronary artery disease: a meta-analysis.
    Wu Z; Lou Y; Jin W; Liu Y; Lu L; Chen Q; Zhang R
    Arch Med Res; 2014 Jan; 45(1):21-30. PubMed ID: 24333099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between GNB3 c.825C > T polymorphism and the risk of overweight and obesity: A meta-analysis.
    Li HL; Zhang YJ; Chen XP; Luo JQ; Liu SY; Zhang ZL
    Meta Gene; 2016 Sep; 9():18-25. PubMed ID: 27114919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
    Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
    Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: a meta-analysis.
    Liu CF; Yang QF; Chen XL; Liu CY
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1241-5. PubMed ID: 22905904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.
    Wu Z; Lou Y; Jin W; Liu Y; Lu L; Lu G
    PLoS One; 2012; 7(12):e53105. PubMed ID: 23300871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and Clinical Implications of TNF-α Promoter and CYP1B1 Gene Variations in Coronary Artery Disease Susceptibility.
    Mir R; Elfaki I; Jha CK; Javid J; Babakr AT; Banu S; Mir MM; Jamwal D; Khullar N; Alzahrani KJ; Chahal SMS
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(4):266-277. PubMed ID: 34939556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.
    Hechmi M; Dallali H; Gharbi M; Jmel H; Fassatoui M; Ben Halima Y; Bahri S; Bahlous A; Abid A; Jamoussi H; Barakat A; Kefi R
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the - 786T>C 1polymorphism in the promoter region of endothelial nitric oxide synthase (eNOS) and risk of coronary artery disease: a systematic review and meta-analysis.
    Liu D; Jiang Z; Dai L; Zhang X; Yan C; Han Y
    Gene; 2014 Jul; 545(1):175-83. PubMed ID: 24135644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
    Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
    BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.